PhereSys Therapeutics(El Dorado Hills, California) reported the opening of its Northeast regional office in the New York metropolitan area as part of its effort to build what it terms is “the nation’s most comprehensive, contract mobile Therapeutic Apheresis network.”

Richard Davis, MD, president, CEO and chairman of PhereSys Therapeutics, said, “The opening of the New York office is a key component of [our] aggressive growth strategy to establish a nationwide footprint. The New York metropolitan area, combined with our existing operations in Southern California, provides access to a total population exceeding 30 million people.”